Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GuideAI Health is a healthcare artificial intelligence company focused on detecting chronic vascular disease from imaging data and helping guide downstream follow-up and patient navigation. The company appears to operate as a healthtech/software business rather than a drug developer, serving radiology practices, hospitals, physicians, and medical device stakeholders with AI-enabled clinical decision support. Public descriptions emphasize early identification of peripheral or chronic vascular disease and workflow support around care coordination. Founded in 2024 and based in Boston, the company is private at the operating-company level, though a related public Canadian entity, GuideAI Health Corp., completed a business combination in June 2026 in preparation for a Cboe Canada listing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GuideAI Health.